Does RAVULIZUMAB-CWVZ Cause Dyspnoea? 414 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 414 reports of Dyspnoea have been filed in association with RAVULIZUMAB-CWVZ. This represents 4.1% of all adverse event reports for RAVULIZUMAB-CWVZ.
414
Reports of Dyspnoea with RAVULIZUMAB-CWVZ
4.1%
of all RAVULIZUMAB-CWVZ reports
5
Deaths
89
Hospitalizations
How Dangerous Is Dyspnoea From RAVULIZUMAB-CWVZ?
Of the 414 reports, 5 (1.2%) resulted in death, 89 (21.5%) required hospitalization, and 3 (0.7%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 414 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
Back pain (326)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Dyspnoea Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST